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INTRODUCTION
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Figure 7. When compared to Day 0, there was a significant increase in
dsDNA at both Day 5 and Day 7 time points (n=3, p<0.05). This
demonstrates the ability of cells to proliferate within the CGF scaffolds.
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Figure 2. This image shows a sample of
the heart valve shaped CG material, post
cross-linking and post infiltration with
fibrin. The material stands up under it’s
own weight and is easy to handle.
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• VSMC proliferation was measured using a PicoGreen assay (see
Figure 7) and live dead cell staining allowed cell viability to be
assessed (see Figure 8).
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• The diameters of the discs were recorded and comparisons
drawn to the fibrin control, which was seeded at the same
seeding density (see Figure 6).

• Collagen and GAGs are ideal natural materials to support fibrin
in this application, as collagen is the major extracellular
component of the native HV, while GAGs provide necessary
fatigue resistance against the repeated shearing between the
different layers of the native heart valve.

Figure 6. Negligible contraction
over 7 days was observed in the
CGF scaffold seeded with VSMCs.
In comparison, fibrin-only scaffolds
with the same seeding density had
contracted to approximately 90% of
their original diameter after 3 days
(n≥9).

Cell number based on DNA flourescence
***

RESULTS

• To develop and characterise a cross-linked, multicomponent
scaffold of collagen, GAG, and fibrin (CGF) in a HV shape.
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• We are currently investigating how a collagen glycosaminoglycan
(GAG) scaffold, infiltrated with fibrin, can provide a fully natural
scaffold, which has sufficient stiffness to resist the contractile
forces of cells acting upon it and thus resist this cell mediated
contraction.

• Vascular smooth muscle cells (VSMCs) were successfully
seeded into 5mm thick CG scaffold discs using an injection
technique with fibrin itself as the carrier and cultured over 7 days
(see Figure 5).

CGF
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• Fibrin has been shown to be an excellent scaffold for HV tissue
engineering studies, however, fibrin based constructs have
shown an inability to maintain an appropriate seal upon closure,
as a result of cell-mediated contraction of the HV leaflets [1,2].

• Mechanical properties of the scaffolds were tested using a
Zwick/Roell Z050 machine (see Figure 4).
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• A tissue engineering approach may provide an effective
alternative by allowing the implanted valve to grow and remodel
with the patient.

• The infiltration of fibrin throughout the CG was assessed using
Masson’s Trichrome staining (see Figure 3).
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• Heart valve (HV) prostheses for paediatric patients have well
documented shortcomings, predominantly related to the need for
multiple surgeries as the child grows.

METHODS

Day 7

Leaflets

• To assess vascular smooth muscle cell (VSMC) distribution, and
response within this CGF scaffold.
• To investigate the cell-mediated contraction of this CGF scaffold
when containing VSMCs.
METHODS
• A HV shaped collagen-GAG (CG) scaffold was fabricated
through freeze drying a CG slurry in a custom built mould (see
Figure 1). Parameters were optimised to produce a CG scaffold
with a homogenous pore size structure.

Figure 3. Masson’s Trichrome staining shows fibrin (red) has
infiltrated through all sections of the collagen-GAG (blue) heart
valve shaped scaffold.
**

Figure 1. We have previously
developed a mould for the
construction of tri-leaflet HV
conduits [1, 3, 4]. This mould was
modified for producing freezedried CG scaffolds.

• Once freeze dried, scaffolds were crosslinked physically by
dehydrothermal (DHT) treatment at 105ºC for 24 hours and crosslinked chemically using 1-Ethyl-3-(3-dimethyl aminopropyl)
carbodiimide (EDAC) in the presence of N-hydroxysuccinimide
(NHS) solution, which stiffens the scaffold while maintaining
elasticity.
• Different concentrations of both collagen and GAG were assessed
to find the most stable concentration of CG to work with.
0.75%Collagen together with 0.044%GAG was found to be the
most stable once injected with fibrin (see Figure 2).

Figure 8. Live/dead staining of VSMCs showing live cells (green)
and dead cells (red) at Day 3 and Day 7 time points (original
magnification: 100X). At Day 3, excellent viability is seen with
some areas of unpopulated scaffold remaining. Day 7 shows
confluent populations of viable cells, supporting the observed
increase in proliferation as demonstrated in Figure 7.
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Figure 4. Tensile testing and compressive testing shows when
fibrin gels are supported with a 0.75%Collagen 0.044%GAG
matrix, their mechanical properties change significantly.
Figure 5. This image shows a CGF
scaffold that was seeded with VSMCs
at a seeding density of 3,000 cells/mm3.
This image was taken after 7 days in
static unrestrained culture. The gel is
12mm in diameter. The CG dry scaffold
was 11mm diameter prior to infiltration
with fibrin containing VSMCs at day 0.

CONCLUSIONS
A crosslinked, multicomponent scaffold of collagen, GAG and fibrin
has been characterised for heart valve applications. Fibrin gels
reinforced with a 0.75% collagen, 0.044% GAG scaffolds can resist
VSMC induced contraction significantly more than fibrin-only gels,
while allowing cell proliferation and maintaining excellent cell viability.
This improvement in structural integrity may facilitate the use of fibrin
based materials for heart valve tissue engineering.
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